Metabolic fate of 18F-FDG in mice bearing either SCCVII squamous cell carcinoma or C3H mammary carcinoma

Journal of Nuclear Medicine

Volumn 43, Issue 7, 2002, Pages 940-947

  Kaarstad, Katrin ^a   Bender, Dirk ^a   Bentzen, Lise ^a   Munk, Ole Lajord ^a   Keiding, Susanne ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

18F FDG PET; C3H mammary carcinoma; SCCVII squamous cell carcinoma; Tumor glucose metabolism

Indexed keywords

2 FLUORO 2 DEOXY 1,6 BIPHOSPHATE F 18; 2 FLUORO 2 DEOXY 6 PHOSPHO DEXTRO GLUCONATE F 18; DRUG METABOLITE; FLUORODEOXYGLUCOSE 6 PHOSPHATE F 18; FLUORODEOXYGLUCOSE F 18; GLUCOSE; UNCLASSIFIED DRUG; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CONTROLLED STUDY; DRUG METABOLISM; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; ANIMAL; C3H MOUSE; CANCER TRANSPLANTATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EXPERIMENTAL NEOPLASM; FEMALE; LIVER; METABOLISM; SCINTISCANNING; TIME;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORODEOXYGLUCOSE F18; LIVER; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; RADIOPHARMACEUTICALS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0035983956     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Oncogenic alternations of metabolism
2. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: Characterization of tumor assessment of the effect of treatment
3. 18F-FDG PET: Histologic and immunohistochemical tissue analysis
4. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography
5. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method
6. 18F]2-deoxy-2-fluoro-D-glucose
7. Enzymatic and cerebral metabolic effects of 2-deoxy-D-glucose
8. Quantitative assessment of tumor metabolism using FDG-PET imaging
9. 11C-methylglucose in pig liver
10. 14C]glucose in plasma and brain: Influence on rate of glucose utilization determined with deoxyglucose method in rat brain
11. 18F]fluoro-2-deoxyglucose in tumor bearing rats: Chromatographic and enzymatic studies
12. Simultaneous and sequential hyperthermia and radiation treatment of an experimental tumor and its surrounding normal tissue in vivo
13. Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement
14. Protein measurement with the Folin-Phenol reagents
15. 19-Fluorine nuclear magnetic resonance spectra of 2-fluoro-2-deoxy-D-glucose and its metabolites
16. 19F NMR spectroscopy
17. 2-Deoxy-2-fluoro-D-glucose as a functional probe for NMR: The unique metabolism beyond its 6-phosphate
18. Reversibility of glucose-6-phosphate oxidation
19. Purification and characterization of hepatic porcine gluconolactonase
20. Reversible oxidation of glucose by glucose dehydrogenase
21. Metabolic pathway of 2-deoxy-2-fluoro-D-glucose studied by F-19 NMR
22. 19F NMR: The effects of anesthesia
23. Incorporation of 2-deoxy-D-glucose into glycogen: Implications for measurement of tissue-specific glucose uptake and utilization
24. 3H]2-deoxyglucose incorporation into neurons and glial cells in invertebrate ganglia: Histological processing of nervous tissue for selective marking of glycogen
25. Complexities underlying the quantitative determination of myocardial glucose uptake with 2-deoxyglucose
26. 14C]deoxyglucose into glycogen in heart and skeletal muscle in vivo
27. A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection
28. Liver kinetics of glucose analogs measured in pigs by PET: Importance of dual-input blood sampling